Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
64.93
+1.08 (+1.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,032,588
Open
64.45
Bid (Size)
65.55 (3)
Ask (Size)
65.80 (2)
Prev. Close
63.85
Today's Range
63.51 - 67.58
52wk Range
8.280 - 99.41
Shares Outstanding
99,581,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Better Buy: Pfizer vs. Viking Therapeutics
Today 9:15 EDT
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
Today 8:15 EDT
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
Performance
YTD
+255.20%
+255.20%
1 Month
-6.16%
-6.16%
3 Month
+179.03%
+179.03%
6 Month
+509.67%
+509.67%
1 Year
+204.41%
+204.41%
More News
Read More
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
Today 7:00 EDT
Via
InvestorPlace
Looking At Viking Therapeutics's Recent Unusual Options Activity
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
Market Whales and Their Recent Bets on VKTX Options
April 18, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
April 15, 2024
Via
Benzinga
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
April 09, 2024
Via
Benzinga
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
Via
InvestorPlace
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
Via
Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
Via
The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
April 12, 2024
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Via
InvestorPlace
Is it Too Late to Buy Viking Therapeutics Stock?
April 06, 2024
Via
The Motley Fool
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
April 04, 2024
Via
The Motley Fool
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
Via
The Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
April 09, 2024
Via
The Motley Fool
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 09, 2024
Via
MarketBeat
Exposures
Product Safety
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
April 08, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/1 - 4/5
April 06, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
April 04, 2024
Via
The Motley Fool
2 Potentially Explosive Stocks to Buy in April
April 04, 2024
Via
The Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.